(Q37434539)

20 August 2017

1 reference

title

Baculovirus vector as a delivery vehicle for influenza vaccines (English)

1 reference

20 August 2017

3

Jimmy Kwang

1 reference

20 August 2017

Fang He

1

1 reference

20 August 2017

Selvaraj Madhan

series ordinal

2

1 reference

20 August 2017

publication date

1 April 2009

1 reference

Expert Review of Vaccines

20 August 2017

published in

1 reference

20 August 2017

volume

8

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

455-467

1 reference

Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses

20 August 2017

cites work

1 reference

Pandemic H5N1 influenza vaccine development: an update.

21 January 2018

1 reference

Avian influenza virus (H5N1): a threat to human health.

21 January 2018

1 reference

H5N1 viruses and vaccines

21 January 2018

1 reference

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

21 January 2018

1 reference

Influenza vaccines and vaccination strategies in birds.

21 January 2018

1 reference

Human infection with highly pathogenic H5N1 influenza virus.

21 January 2018

1 reference

Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine

21 January 2018

1 reference

Expression and production of human interleukin-7 in insect cells using baculovirus expression vector system (BEVS).

21 January 2018

1 reference

Expression of biologically active measles virus hemagglutinin glycoprotein by a recombinant baculovirus.

21 January 2018

1 reference

Baculovirus expression and bioactivity of a soluble 140 kDa extracellular cleavage fragment of L1 neural cell adhesion molecule

21 January 2018

1 reference

Successful expression and purification of human CIAPIN1 in baculovirus-insect cell system and application of this system to investigation of its potential methyltransferase activity.

21 January 2018

1 reference

Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture

21 January 2018

1 reference

Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccine.

21 January 2018

1 reference

Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate

21 January 2018

1 reference

A surface-modified baculovirus vector with improved gene delivery to B-lymphocytic cells.

21 January 2018

1 reference

RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells

21 January 2018

1 reference

A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties.

21 January 2018

1 reference

Baculovirus expression vectors for insect and mammalian cells

21 January 2018

1 reference

Gene expression in mammalian cells using BacMam, a modified baculovirus system

21 January 2018

1 reference

Baculovirus as a highly efficient expression vector in insect and mammalian cells.

21 January 2018

1 reference

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

21 January 2018

1 reference

High efficiency gene transfer into mammalian kidney cells using baculovirus vectors.

21 January 2018

1 reference

Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo

21 January 2018

1 reference

In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors

21 January 2018

1 reference

Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector.

21 January 2018

1 reference

Recombinant baculoviruses as mammalian cell gene-delivery vectors

21 January 2018

1 reference

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

21 January 2018

1 reference

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.

21 January 2018

1 reference

Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

21 January 2018

1 reference

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

21 January 2018

1 reference

Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus

21 January 2018

1 reference

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.

21 January 2018

1 reference

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine

21 January 2018

1 reference

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

21 January 2018

1 reference

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

21 January 2018

1 reference

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.

21 January 2018

1 reference

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

21 January 2018

1 reference

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

21 January 2018

1 reference

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine

21 January 2018

1 reference

Live cold-adapted influenza A vaccine produced in Vero cell line

21 January 2018

1 reference

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.

21 January 2018

1 reference

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

21 January 2018

1 reference

Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus

21 January 2018

1 reference

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.

21 January 2018

1 reference

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

Influenza vaccine: the challenge of antigenic drift.

21 January 2018

1 reference

Changing perspective on immunization against influenza

21 January 2018

1 reference

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

21 January 2018

1 reference

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

21 January 2018

1 reference

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

21 January 2018

1 reference

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

21 January 2018

1 reference

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

21 January 2018

1 reference

Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids.

21 January 2018

1 reference

Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system

21 January 2018

1 reference

Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue

21 January 2018

1 reference

Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.

21 January 2018

1 reference

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

21 January 2018

1 reference

21 January 2018

1 reference

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

21 January 2018

1 reference

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

21 January 2018

1 reference

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

21 January 2018

1 reference

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

Expanding baculovirus surface display. Modification of the native coat protein gp64 of Autographa californica NPV.

21 January 2018

1 reference

Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase

21 January 2018

1 reference

Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity

21 January 2018

1 reference

Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential

21 January 2018

1 reference

Display of heterologous proteins on gp64null baculovirus virions and enhanced budding mediated by a vesicular stomatitis virus G-stem construct

21 January 2018

1 reference

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

21 January 2018

1 reference

WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine

21 January 2018

1 reference

Baculovirus immediate-early promoter-mediated expression of the Zeocin resistance gene for use as a dominant selectable marker in dipteran and lepidopteran insect cell lines

21 January 2018

1 reference

Microarray and RT-PCR screening for white spot syndrome virus immediate-early genes in cycloheximide-treated shrimp

21 January 2018

1 reference

Efficient gene delivery into mammalian cells mediated by a recombinant baculovirus containing a whispovirus ie1 promoter, a novel shuttle promoter between insect cells and mammalian cells

21 January 2018

1 reference

Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity

21 January 2018

1 reference

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

21 January 2018

1 reference

Emerging vaccines for influenza

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.2

1 reference

20 August 2017

1 reference